hydroxychloroquine + mycophenolate mofetil + prednisolone + tacrolimus

A combination of four immunomodulatory/immunosuppressive medications used for treating severe autoimmune conditions. The combination includes: - **Hydroxychloroquine**: A disease-modifying anti-rheumatic drug (DMARD) that suppresses Toll-like receptor activation and modulates immune system activity - **Mycophenolate mofetil**: An immunosuppressant that inhibits purine synthesis in lymphocytes - **Prednisolone**: A corticosteroid with broad anti-inflammatory and immunosuppressive effects - **Tacrolimus**: A potent calcineurin inhibitor that prevents T-cell activation and proliferation This combination provides multi-pathway immunosuppression and may be used in severe autoimmune conditions or complex cases requiring significant immune system modulation.